Peripheral Neuropathy

Published:December 17, 2018DOI:https://doi.org/10.1016/j.mcna.2018.10.006

      Keywords

      To read this article in full you will need to make a payment
      Purchase one-time access
      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
      Content published before 2002 is available via pay-per-view purchase only.
      Subscribe to Medical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tesfaye S.
        • Selvarajah D.
        Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy.
        Diabetes Metab Res Rev. 2012; 28: 8-14
        • Gregg E.W.
        • Sorlie P.
        • Paulose-Ram R.
        • et al.
        Prevalence of lower-extremity disease in the U.S. adult population ≥40 years of age with and without diabetes: 1999–2000 national health and nutrition examination survey.
        Diabetes Care. 2004; 27: 1591-1597
        • Tesfaye S.
        • Vileikyte L.
        • Rayman G.
        • et al.
        Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management: painful diabetic peripheral neuropathy.
        Diabetes Metab Res Rev. 2011; 27: 629-638
        • Stino A.M.
        • Smith A.G.
        Peripheral neuropathy in prediabetes and the metabolic syndrome.
        J Diabetes Investig. 2017; 8: 646-655
        • Zilliox L.
        • Russell J.W.
        Treatment of diabetic sensory polyneuropathy.
        Curr Treat Options Neurol. 2011; 13: 143-159
        • Spallone V.
        • Ziegler D.
        • Freeman R.
        • et al.
        Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management: diabetic cardiovascular autonomic neuropathy in clinical practice.
        Diabetes Metab Res Rev. 2011; 27: 639-653
        • Freeman R.
        Autonomic peripheral neuropathy.
        Lancet. 2005; 365: 1259-1270
        • Lacomis D.
        Clinical utility of peripheral nerve biopsy.
        Curr Neurol Neurosci Rep. 2005; 5: 41-47
        • Vital C.
        • Vital A.
        • Canron M.H.
        • et al.
        Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases.
        J Peripher Nerv Syst. 2006; 11: 20-29
        • Lauria G.
        • Hsieh S.T.
        • Johansson O.
        • et al.
        European Federation of Neurological Societies/peripheral nerve society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe-deration of Neurological Societies and the Peripheral Nerve Society.
        Eur J Neurol. 2010; 17: e44-e49
        • Bianchi S.
        Ultrasound of the peripheral nerves.
        Joint Bone Spine. 2008; 75: 643-649
        • Callaghan B.C.
        • Kerber K.A.
        • Lisabeth L.L.
        • et al.
        Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy.
        JAMA Neurol. 2014; 71: 1143-1149
        • Smith A.G.
        Do all neuropathy patients need an EMG at least once?.
        Continuum (Minneap Minn). 2014; 20: 1430-1434
        • England J.D.
        • Gronseth G.S.
        • Franklin G.
        • et al.
        Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review): report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation.
        Neurology. 2009; 72: 185-192
        • Papanas N.
        • Vinik A.I.
        • Ziegler D.
        Neuropathy in prediabetes: does the clock start ticking early?.
        Nat Rev Endocrinol. 2011; 7: 682-690
        • Gibbons C.H.
        • Freeman R.
        Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes.
        Brain. 2015; 138: 43-52
        • Callaghan B.C.
        • Little A.A.
        • Feldman E.L.
        • et al.
        Enhanced glucose control for preventing and treating diabetic neuropathy.
        Cochrane Database Syst Rev. 2012; (CD007543)
        • Smith A.G.
        • Russell J.
        • Feldman E.L.
        • et al.
        Lifestyle intervention for pre-diabetic neuropathy.
        Diabetes Care. 2006; 29: 1294-1299
        • Balducci S.
        • Iacobellis G.
        • Parisi L.
        • et al.
        Exercise training can modify the natural history of diabetic peripheral neuropathy.
        J Diabetes Complications. 2006; 20: 216-223
      1. Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Available at: http://www.biomedsearch.com/article/Peripheral-neuropathy-pathogenic-mechanisms-alternative/157656145.html. Accessed June 15, 2018.

        • Oyenihi A.B.
        • Ayeleso A.O.
        • Mukwevho E.
        • et al.
        Antioxidant strategies in the management of diabetic neuropathy.
        Biomed Res Int. 2015; 2015: 515042
        • Grisold W.
        • Cavaletti G.
        • Windebank A.J.
        Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.
        Neuro Oncol. 2012; 14: iv45-iv54
        • Chopra K.
        • Tiwari V.
        Alcoholic neuropathy: possible mechanisms and future treatment possibilities.
        Br J Clin Pharmacol. 2012; 73: 348-362
        • Fogelman Y.
        • Kitai E.
        • Blumberg G.
        • et al.
        Vitamin B12 screening in metformin-treated diabetics in primary care: were elderly patients less likely to be tested?.
        Aging Clin Exp Res. 2017; 29: 135-139
        • Kumar N.
        • Gross J.B.
        Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration.
        Neurology. 2004; 63: 33-39
        • Traber M.G.
        • Sokol R.J.
        • Ringel S.P.
        • et al.
        Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral Ne27uropathy.
        N Engl J Med. 1987; 317: 262-265
        • Abdou E.
        • Hazell A.S.
        Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations.
        Neurochem Res. 2015; 40: 353-361
        • Berger A.R.
        • Schaumburg H.H.
        • Schroeder C.
        • et al.
        Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity.
        Neurology. 1992; 42: 1367-1370
        • Kulkantrakorn K.
        Pyridoxine-induced sensory ataxic neuronopathy and neuropathy: revisited.
        Neurol Sci. 2014; 35: 1827-1830
        • Kelly J.J.
        • Kyle R.A.
        • O’Brien P.C.
        • et al.
        Prevalence of monoclonal protein in peripheral neuropathy.
        Neurology. 1981; 31: 1480-1483
        • Kyle R.A.
        • Therneau T.M.
        • Rajkumar S.V.
        • et al.
        A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
        N Engl J Med. 2002; 346: 564-569
        • Raheja D.
        • Specht C.
        • Simmons Z.
        Paraproteinemic neuropathies.
        Muscle Nerve. 2014; 51: 1-13
        • Chaudhry H.M.
        • Mauermann M.L.
        • Rajkumar S.V.
        Monoclonal gammopathy–associated peripheral neuropathy: diagnosis and management.
        Mayo Clin Proc. 2017; 92: 838-850
        • Lunn M.P.
        • Nobile-Orazio E.
        Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
        Cochrane Database Syst Rev. 2016; (CD002827)
        • Planté-Bordeneuve V.
        • Said G.
        Familial amyloid polyneuropathy.
        Lancet Neurol. 2011; 10: 1086-1097
        • Sheikh S.I.
        • Amato A.A.
        The dorsal root ganglion under attack: the acquired sensory ganglionopathies.
        Pract Neurol. 2010; 10: 326-334
        • Younger D.S.
        Vasculitis of the nervous system.
        Curr Opin Neurol. 2004; 17: 317-336
        • Dimachkie M.M.
        • Barohn R.J.
        Guillain-Barré syndrome and variants.
        Neurol Clin. 2013; 31: 491-510
        • Dyck P.J.B.
        • Windebank A.J.
        Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment.
        Muscle Nerve. 2002; 25: 477-491
        • Saporta M.A.
        Charcot-Marie-Tooth disease and other inherited neuropathies.
        Continuum (Minneap Minn). 2014; 20: 1208
        • Thomson R.M.
        • Parry G.J.
        Neuropathies associated with excessive exposure to lead.
        Muscle Nerve. 2006; 33: 732-741
        • Tiryaki E.
        • Horak H.A.
        ALS and other motor neuron diseases.
        Continuum (Minneap Minn). 2014; 20: 1185
        • Parry G.J.G.
        Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy.
        Muscle Nerve. 1994; 17: 97-99
        • Nobile-Orazio E.
        • Gallia F.
        Multifocal motor neuropathy: current therapies and novel strategies.
        Drugs. 2013; 73: 397-406
        • Ghasemi-rad M.
        • Nosair E.
        • Vegh A.
        • et al.
        A handy review of carpal tunnel syndrome: from anatomy to diagnosis and treatment.
        World J Radiol. 2014; 6: 284-300
        • Mintalucci D.J.
        • Leinberry C.F.
        Open versus endoscopic carpal tunnel release.
        Orthop Clin North Am. 2012; 43: 431-437
        • Albers J.W.
        • Fink J.K.
        Porphyric neuropathy.
        Muscle Nerve. 2013; 30: 410-422
        • Attal N.
        • Cruccu G.
        • Baron R.
        • et al.
        EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision: treatment of neuropathic pain.
        Eur J Neurol. 2010; 17: 1113-e88
        • Griebeler M.L.
        • Morey-Vargas O.L.
        • Brito J.P.
        • et al.
        Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis.
        Ann Intern Med. 2014; 161: 639
        • Callaghan B.C.
        • Feldman E.L.
        Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs.
        Ann Intern Med. 2014; 161: 674
        • Brunelli B.
        • Gorson K.C.
        The use of complementary and alternative medicines by patients with peripheral neuropathy.
        J Neurol Sci. 2004; 218: 59-66
        • Richardson J.K.
        • Hurvitz E.A.
        Peripheral neuropathy: a true risk factor for falls.
        J Gerontol A Biol Sci Med Sci. 1995; 50A: M211-M215
        • Taylor-Stokes G.
        • Pike J.
        • Sadosky A.
        • et al.
        Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy.
        Diabetes Metab Syndr Obes. 2011; 4: 401-408
        • Freeman R.
        • Miyawaki E.
        The treatment of autonomic dysfunction.
        J Clin Neurophysiol. 1993; 10: 61-82
        • Finnerup N.B.
        • Otto M.
        • McQuay H.J.
        • et al.
        Algorithm for neuropathic pain treatment: an evidence based proposal.
        Pain. 2005; 118: 289-305
        • Dworkin R.H.
        • O'Connor A.B.
        • Backonja M.
        • et al.
        Pharmacologic management of neuropathic pain: evidence-based recommendations.
        Pain. 2007; 132: 237-251